Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)
13 Janeiro 2021 - 8:03AM
Edgar (US Regulatory)
TIDMUSFM
RNS Number : 5582L
UBS ETF MSCI US SEL Factor Mix USD
13 January 2021
Fund UBS (Irl) ETF plc - MSCI USA Select Factor Mix UCITS ETF (USD) A-Dis
ISIN Code IE00BDGV0308
Dealing Date 12/01/2021
NAV per Share 25.4339
Base Currency USD
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NAVGPUUUGUPGGGW
(END) Dow Jones Newswires
January 13, 2021 06:06 ET (11:06 GMT)
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024
Notícias em tempo-real sobre Sunesis Pharmaceuticals Inc da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Sunesis Pharmaceuticals Inc